![]() |
|
|
Vol. 295, Issue 2, 484-491, November 2000
Vascular Biology Laboratory, Dalton Cardiovascular Research Center, and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri (B.J.F.H., B.R.W., M.S.); and Department of Physiology, School of Medicine, East Carolina University, Greenville, North Carolina (L.C.K.)
| |
Abstract |
|---|
|
|
|---|
Arterial injury models for coronary artery disease have demonstrated an
enhanced expression and function of either the endothelinA or endothelinB (ETA or ETB)
receptor subtype. We hypothesized that organ culture would enhance the
physiological function of ET receptors in the porcine right coronary
artery. Arteries were either cold stored (4°C) or organ cultured
(37°C) for 4 days. After 4 days, the artery was either 1) sectioned
into rings to measure the ET-1-induced isometric tension response
(3 × 10
10-3 × 10
7 M), or 2)
enzymatically dispersed and the isolated smooth muscle cells imaged
using fura-2 to measure the myoplasmic calcium (Cam) response to 3 × 10
8 M ET-1 (~EC50).
Isometric tension and Cam to ET-1 were measured in the
absence and presence of bosentan (nonselective ETA or
ETB receptor antagonist), BQ788 (ETB-selective
antagonist), and BQ123 (ETA-selective antagonist). Compared
with cold storage, organ culture induced a 2-fold increase in tension
development (3 × 10
7 M ET-1) and Cam
(3 × 10
8 M ET-1), which was inhibited with
bosentan, thus confirming the enhanced responses to ET-1 were due to ET
receptor activation. BQ123 also inhibited the enhanced contraction and
Cam responses to ET-1. In contrast, BQ788 failed to inhibit
tension development and Cam responses to ET-1 in organ
culture and cold storage. Sarafotoxin 6C (ETB agonist)
failed to elicit an increased Cam response in organ culture
compared with cold storage. Our results indicate the increased tension
development and Cam responses to ET-1 in organ culture are
attributable to ETA receptors, and not ETB receptors.
| |
Introduction |
|---|
|
|
|---|
Endothelin-1
(ET-1) is a potent vasoconstrictor and mitogen of vascular smooth
muscle cells (Harrison et al., 1992
; Mathew et al., 1996
). Smooth
muscle cells contain both the ETA and
ETB receptor subtypes; however, the relative
subtype distribution varies depending on the vessel type (Godfraind,
1993
; Adner et al., 1998a
). In coronary arteries the
ETA receptor subtype predominates; approximately
80% of the contractile response is attributed to the
ETA receptor, whereas ETB
is responsible for the remaining 20% (Dagassan et al., 1996
; Elmoselhi
and Grover, 1997
).
The selective up-regulation of either subtype is enhanced with the
progression of atherosclerosis, thrombosis, and cardiac hypertrophy
(Wang et al., 1995
; Mathew et al., 1996
; Stewart, 1998
). Evidence
suggests either ET receptor subtype may contribute to the enhanced
contractile response to ET with arterial injury (Harrison et al., 1992
;
Wang et al., 1995
; Dagassan et al., 1996
; White et al., 1998
). Coronary
artery disease is a leading cause of death in the U.S. population
(Russell et al., 1998
); therefore, it is important to understand the
role of ET-1 receptors in this artery. Few investigators have studied
the functional response to ET-1 in a coronary artery injury model.
Dagassan et al. (1996)
described an up-regulation of
ETB receptors in the left anterior descending
(LAD) coronary artery from humans displaying atherosclerosis. Hasdai et
al. (1997)
also found enhanced ETB-mediated
vasoconstriction in the left circumflex coronary artery from
hyperlipidemic pigs. In contrast, Katwa et al. (1999)
and Wang et al.
(1995)
demonstrated increased ETA function in the
right coronary artery and the LAD coronary artery, respectively, with
arterial injury. However, Godfraind (1993)
found that there is a high
degree of heterogeneity of ETA and
ETB receptors along the length of the LAD.
ET-1-induced contractions are mediated almost entirely by
ETA receptors at the distal end of the LAD,
whereas ETB receptors are partially responsible
for the contraction at the proximal end. To eliminate this large degree
of heterogeneity we used the right coronary artery because it has a
predominant ETA receptor population that is
responsible for mediating vasoconstriction (Bacon and Davenport, 1996
;
Schiffrin and Touyz, 1998
). In this study we hypothesized that arterial
injury (i.e., organ culture) would enhance ET receptor-mediated vasoconstriction and myoplasmic calcium (Cam)
responses in the porcine right coronary artery.
Organ culture is a technique that has been used to study cell
proliferation in vessels (Gotlieb and Boden, 1984
; Newby and Zaltsman,
1999
; Voisard et al., 1999
). Newby and Zaltsman (1999)
recently
demonstrated medial proliferation of smooth muscle cells within the
organ-cultured rabbit and pig aorta, as well as human saphenous veins.
They indicate that organ culture greatly parallels chemotaxis and
matrixes remodeling in animal models because of the intact interactions
that are present within organ culture. Recently, Voisard et al. (1999)
pointed out that organ culture is a valuable model that mimics the
injury response of atherosclerosis.
This study uniquely demonstrates that the Cam response mediated by ETA or ETB receptors in isolated smooth muscle cells is paralleled by the development of isometric tension in both cold-stored and organ-cultured coronary arteries. Our results indicate that the 2-fold increase in Cam and tension development to ET-1 with organ culture is attributed to ETA receptors, and not ETB receptors.
| |
Materials and Methods |
|---|
|
|
|---|
Organ Culture and Single-Cell Fura-2 Digital Imaging.
Hearts
were obtained from local abattoirs and prepared as described in our
laboratory (Sturek et al., 1991
). Right coronary arteries (distal end)
were either cold stored for 4 days at 5°C or organ cultured for 4 days at 37°C in a 95% O2, 5%
CO2 incubator. The arterial segments that were
organ cultured or cold stored were opened longitudinally to expose the
lumen and placed with the lumen facing up in a 100-mm Petri dish
containing 30 ml of RPMI 1640 (Life Technologies, Grand Island,
NY). The RPMI 1640 was changed every 2 days.
6 M fura-2-acetoxymethyl ester at
37°C for 25 min. In those experiments using antagonists, cells were
incubated for 1 h with the appropriate concentration of the
antagonist before commencing with single-cell digital imaging. A drop
of the fura-2-loaded cellular suspension was placed on a coverslip
inside a constant flow superfusion chamber (Science Instruments Shop,
University of Missouri, Columbia, MO), which was mounted on an inverted
epifluorescence microscope (model TMS-F; Nikon, Melville,
NY). Cells were allowed to settle and adhere to the coverslip
(Fig. 5A, inset) before commencing with the experiments. Fura-2 was
excited by 340- and 380-nm light and the emitted fluorescence (510 nm)
collected by a monochrome charge-coupled device camera (Cohu, Inc., San
Diego, CA) that was attached to a computer for data aquisition by the
InCa ratiometric fluorescence program, version 1.2 (Intracellular
Imaging Inc.). Data are expressed as a ratio (and indicated as ratio
units) of the emitted light intensity at 340- and 380-nm excitation
rather than [Ca2+m]
because of uncertainties, mainly impaired calcium sensitivity, detailed
in previous reports (Sturek et al., 1991DNA Imaging.
Cold-stored and organ-cultured arteries were
fixed in 4% paraformaldehyde and incubated for 24 h in 30%
sucrose at (20°C). Arteries were freeze mounted and cut into 7-µm
sections. Cross sections were stained with 2.5 × 10
7 M 4',6-diamidino-2-phenylindole
dihydrochloride (DAPI) for 20 min at 37°C to quantitate single-cell
DNA content (Kapuscinski, 1995
). Imaging of DAPI fluorescence was done
using a widefield epifluorescent microscope (Nikon Diaphot, Garden
City, NY). Images at three focal planes 0.5 µm apart in the
z-axis were acquired for deconvolution analysis.
Out-of-focus fluorescence was removed by deconvolution software
equipped with a digital signal processing board that used the nearest
neighbor algorithm (Vaytek, Inc., Fairfield, IA). DAPI fluorescence was
quantitated using Image Pro Plus 3.0 software (Media Cybernetics,
Silver Springs, MD).
Isometric Tension Measurements.
Similar to the single-cell
imaging experiments, porcine right coronary arteries were sectioned and
placed in a Petri dish containing RPMI 1640 for cold storage or organ
culture. After 4 days, vessel segments were sectioned into 5-mm rings
and the endothelium removed using a toothpick. Rings were also further studied within 3 h after the sacrifice of the pig. The absence of
an intact endothelium was confirmed by the lack of a relaxation response to 1 × 10
7 M bradykinin. Rings
were mounted via two stainless steel wire supports in 25 ml of isolated
organ baths maintained at 37°C, and the physiological salt solution
(PSS) aerated with a 95% O2, 5%
CO2 mixture. The two support wires were connected
to an isometric force transducer (Grass Medical Instruments, Quincy,
MA) and a linear displacement micrometer (Mitutoyo, MTI Corp., Paramus, NJ). Force generation was amplified by a custom-designed amplifier (Technical Resources Core Facility, Dalton Cardiovascular Research Center), and the data acquired by a computer equipped with an analog-to-digital converter and Labtech Acquire software (Laboratory Technologies Corp., Wilmington, MA). Rings were set near their optimum
length-tension relationship by progressively lengthening each ring and
subsequently contracting it with the addition of a 60 × 10
3 M KCl solution to the organ bath. This
procedure was repeated until the active force generated was no more
than 10% greater than at the previous length. Rather than stretching
all vessel rings to the same passive tension, the method of setting
each vessel at optimal length was chosen to reduce variability and maximize the response of each vessel ring. Rings were initially exposed
to an 80 × 10
3 M KCl solution (80K)
before exposing them to ET-1. In those experiments using antagonists,
cells were incubated for 45 min with the appropriate concentration of
the antagonist before generating a cumulative concentration-response
relationship to ET-1 in half-log increments (3 × 10
10-3 × 10
7 M).
Solutions.
Isolated smooth muscle cells within the
superfusion chamber were continually superfused with PSS containing
138 × 10
3 M NaCl, 5 × 10
3 M KCl, 2 × 10
3 M CaCl2, 1 × 10
3 M MgCl2, 10 × 10
3 M HEPES, 10 × 10
3 M glucose, titrated to pH 7.4 (with NaOH).
The depolarizing solution (80K or 25 × 10
3 M KCl solution) was composed of 65 × 10
3 M NaCl, 80 or 25 × 10
3 M KCl, 2 × 10
3 M CaCl2, 1 × 10
3 M MgCl2, 10 × 10
3 M HEPES, 10 × 10
3 M glucose, titrated to pH 7.4 (with NaOH).
For isometric tension measurements the PSS was similar to that for
single cells except that 24 × 10
3 M
NaHCO3 was added and NaCl was reduced by 24 × 10
3 M. The stock solution of potassium
chloride (Sigma Chemical Co.) was prepared in distilled water.
Fura-2-acetoxymethyl ester (Molecular Probes, Inc., Eugene, OR), BQ123
(Peptides International, Louisville, KY), PD145065 (Sigma Chemical
Co.), and BQ788 (Peptides International) were prepared in dimethyl
sulfoxide (Sigma Chemical Co.). DAPI (Molecular Probes, Inc.) and
endothelin-1 (Peninsula Labs, Inc., San Carlos, CA) were prepared in
N,N-dimethyl-formamide (Sigma Chemical Co.) and
0.01 N acetic acid, respectively. Bosentan was a gift from Roche
Pharmaceuticals (Nutley, NJ). Drugs to be used within the
superfusion system were diluted from stock solutions into PSS and
superfused at a rate of approximately 2 ml/min.
Statistical Analysis.
Data were expressed as the mean ± S.E. for the number (n) of single cells (fura-2 imaging)
or animals (isometric tension) within each group. Analysis of data was
done by either a one-way ANOVA or a Kruskal-Wallis one-way ANOVA
followed by Bonferroni's test or Dunn's test, respectively, when more
than two groups were present. A paired or unpaired Student's
t test was used when comparing only two groups. Smooth
muscle cells that were identified as "responders" to an agonist
were defined as those cells whose response to an agonist was at least
three standard deviations above the baseline for 5% of the time
exposed to the agonist (P < .01). The percentage of
responders was analyzed using the chi square distribution. Statistical
analyses of the data were performed using SigmaStat (Jandel Scientific
Software, San Rafael, CA). The pD2
values (
log EC50) were calculated and analyzed
using GraphPad Prism 2.0 (GraphPad Software Inc., San Diego, CA).
Significance was defined as P < .05.
| |
Results |
|---|
|
|
|---|
A concentration-response relationship (3 × 10
10-3 × 10
7 M)
to ET-1 was generated in fresh (n = 8) and cold-stored
arterial rings (n = 18). The
pD2 values (
log
EC50) in fresh and cold-stored rings (7.96 ± 0.23 and 7.60 ± 0.13, respectively) were not significantly different. Additionally, isometric tension development (96 ± 12 and 121 ± 8%, respectively) to a maximal concentration
(Tmax) of ET-1 (3 × 10
7 M) was not significantly different between
fresh and cold-stored rings. We have previously demonstrated (M. Sturek, B. Hill, and B. Wamhoff, unpublished observations) using
isolated single smooth muscle cells from fresh and cold-stored arteries
that there is no difference in the basal Cam
concentration or the peak Cam response to 5 × 10
3 M caffeine or 80K between groups,
suggesting cold-stored arteries serve as an adequate paired time
control for those arteries that were organ cultured.
A cumulative concentration-response relationship to ET-1 was generated
from 3 × 10
10 to 3 × 10
7 M in arterial rings that had been organ
cultured (n = 20). As demonstrated in Fig.
1, organ-cultured rings demonstrated a
significant increase (227 ± 20%) in their
Tmax to 3 × 10
7 M ET-1 compared with cold-stored rings
(121 ± 8%; n = 18). However, there was no
difference in potency (pD2) to ET-1
between cold-stored and organ-cultured rings (7.60 ± 0.13 and
7.56 ± 0.03, respectively). The 2-fold increase in the
Tmax of organ-cultured rings indicates organ culture may enhance the physiological function of ET receptors to
elicit a contraction. To identify whether either the
ETA or ETB subtype
contributes to this increased tension development, a
concentration-response relationship was generated to ET-1 in the
absence and presence of bosentan (ETA and
ETB antagonist), PD145065
(ETA and ETB antagonist),
BQ123 (ETA antagonist), and BQ788
(ETB antagonist).
|
Bosentan (10
6 M), a nonselective ET antagonist,
inhibited isometric tension development to ET-1 in organ-cultured and
cold-stored arterial rings as indicated by the significant rightward
shift of the concentration-response relationship to ET-1 (Fig.
2; Table 1). In cold-stored rings, the
pD2 value in the absence of bosentan was 7.95 ± 0.10. The pD2 could
not be calculated in cold-stored rings in the presence of bosentan
because a sigmoidal concentration-response relationship was not
generated. In organ-cultured rings, the
pD2 values in the absence and presence
of bosentan were 7.57 ± 0.05 and 6.78 ± 0.14, respectively.
Bosentan did not significantly affect the
Tmax in organ-cultured and cold-stored
rings. In addition, another ETA and
ETB antagonist, PD145065
(10
6 M), similarly shifted the ET-1
concentration-response relationship to ET-1 to the right in both
cold-stored and organ-cultured rings (data not shown).
|
|
Selective inhibition of isometric tension development was determined
using the selective ETA antagonist BQ123 (Table
1). In cold-stored rings, only 10
5 M BQ123
(Fig. 3A) significantly inhibited the
concentration-response relationship to ET-1; no inhibition was
demonstrated using 10
6 M BQ123 (Fig. 3B). In
contrast, both 10
6 M (Fig. 3B) and
10
5 M (Fig. 3A) BQ123 shifted the
concentration-response relationship (i.e.,
pD2 values) to the right 5- and
7-fold, respectively, in organ-cultured rings. As shown by Fig.
4, selective inhibition of the
ETB receptor with BQ788
(10
5 or 10
6 M BQ788)
did not alter the pD2 value or the
Tmax in the cold-stored and
organ-cultured arterial rings (Table 1). Using cardiac fibroblasts we
have confirmed the antagonistic activity of BQ788, which contain both
ETA and ETB receptors (data
not shown).
|
|
To further investigate the altered contractile function of ET
receptors, smooth muscle cells were enzymatically isolated from both
cold-stored and organ-cultured arteries, and the
Cam response measured to 3 × 10
8 M ET-1 in the absence and presence of
10
5 M bosentan, BQ123, and BQ788 (Fig.
5, A and B). We used 3 × 10
8 M ET-1 because this was the approximate
EC50 value (pD2 = 7.5) for the concentration-response relationship generated to ET-1 in
cold-stored and organ-cultured arterial rings. Previous observations indicate that not all cells respond to ET-1 in the absence of an
antagonist; however, in evaluating the effect of antagonists on the
Cam response all cells (both responders and
nonresponders) were pooled. All cells were pooled because it would not
be known whether the nonresponders to ET-1 inherently did not respond
to ET-1, or whether the antagonist effectively inhibited the
Cam response to ET-1. Because our reported
results include both responders and nonresponders to ET-1, the reported
Cam response to ET-1 will be lower (due to the
"dilution" of the Cam response to ET-1 by the
nonresponders) than if calculated for just those cells responding to
ET-1. Similar to the development of isometric tension in arterial rings, cells from organ-cultured arteries had a significantly increased
Cam response to ET-1 (0.50 ± 0.05 ratio
units; n = 20) compared with those cells from
cold-stored arteries (0.19 ± 0.03 ratio units; n = 24). Bosentan significantly decreased the ET-1-induced Cam response in cells from both cold-stored
(0.09 ± 0.02 ratio units; n = 29) and
organ-cultured (0.10 ± 0.03 ratio units; n = 14)
arteries compared with the paired control cells without bosentan
(0.19 ± 0.03 and 0.50 ± 0.05 ratio units, respectively). In
cells from organ culture, BQ123 also significantly decreased the
Cam response (0.13 ± 0.04 ratio units;
n = 14) to similar levels as bosentan. BQ788 had little
effect (P > .05) on the ET-1 response (0.37 ± 0.05 ratio units; n = 18) in cells from organ culture.
In cells from cold-stored arteries, both BQ123 (0.19 ± 0.04 ratio
units; n = 19) and BQ788 (0.27 ± 0.03 ratio
units; n = 20) did not significantly decrease the
Cam response to ET-1.
|
In agreement with data generated by both isometric tension recordings
and single-cell Cam responses to ET-1 in the
presence of BQ788, the selective ETB receptor
agonist sarafotoxin 6C (10
8 M), did not
significantly increase Cam above basal levels in isolated cells from cold-stored and organ-cultured arteries (Fig. 6). Sarafotoxin 6C has been extensively
used as an ETB agonist in vascular smooth muscle
(Adner et al., 1998a
; White et al., 1998
). We previously found
that 10
8 M sarafotoxin 6C elicited a similar
Cam response as 10
7 M
sarafotoxin 6C. Previously, we determined that not all cells respond to
ET-1 and sarafotoxin 6C; therefore, the Cam
response was determined only in those cells that responded to the
agonists (Fig. 6). In cells isolated from organ-cultured arteries, 75% (15 of 20) responded to ET-1, whereas only 14% (5 of 35) responded to
sarafotoxin 6C. However, in cells from cold-stored arteries, 33% (4 of
12) and 35% (9 of 26) of the cells responded to ET-1 and sarafotoxin
6C, respectively. As shown in Fig. 6, ET-1 elicited a significantly
increased Cam response of 0.47 ± 0.10 ratio
units above baseline in isolated cells from organ culture compared with the Cam response in cells from cold-stored
arteries (0.07 ± 0.03 ratio units). In contrast to ET-1, the
Cam response to sarafotoxin 6C was significantly
decreased with organ culture (0.04 ± 0.03 ratio units) compared
with cold storage (0.11 ± 0.04 ratio units).
|
This study, as well as previous studies by our lab (Wagner-Mann and
Sturek, 1991
, 1992
), indicate that the peak Cam
response elicited to ET-1 in isolated smooth muscle cells was
predominantly due to the release of calcium from the sarcoplasmic
reticulum (SR). However, our lab and others (Goto et al., 1989
;
Wagner-Mann and Sturek, 1991
) have shown that ET-1 does appear to
induce a very small amount of calcium influx (which has a negligible
contribution to the peak Cam response) via
voltage-gated calcium channels after the initial release of the SR
calcium store. In our study, the minimal contribution of calcium influx
to the peak Cam response is demonstrated by the
absence of a sustained "plateau" phase after the initial transient
calcium spike (due to SR calcium release; Fig. 5A) after ET-1
application in cells from both cold-stored and organ-cultured arteries.
In our preparation, this lack of a measurable sustained calcium influx
in response to ET-1 is due to the rapid extrusion of calcium from the
cell (Rasmussen et al., 1989
; Bowles et al., 1995
). We demonstrated
that ET-1-induced tension development is, in a large part, due to
sustained calcium influx by exposing arterial rings to ryanodine
(10
5 M) for 50 min, which our lab previously
documented mobilizes and fully depletes the SR calcium store
(Wagner-Mann and Sturek, 1991
, 1992
). Subsequent to ryanodine, 5 × 10
8 M ET-1 was applied for 25 min, which
induced a significant contractile response.
Cold-stored (Fig. 7A; n = 5) and organ-cultured (Fig. 7B; n = 5) artery sections
were stained with DAPI, an indicator of DNA content. DAPI fluorescence
has extensively been used to measure nuclear DNA content in cells
(Seiler et al., 1993
; Kapuscinski, 1995
). Previous investigators have
confirmed that the relative DAPI fluorescence intensity is directly
related to both DNA content (Seiler et al., 1993
) and cell
proliferation (McCaffrey et al., 1988
). There was a significant
increase in the amount of DAPI fluorescence in single smooth muscle
cells (Fig. 7C) from the cross-sectioned, organ-cultured (164.60 ± 3.55) compared with cold-stored (96.09 ± 2.64) arteries. In
addition, DAPI-stained nuclei in organ-cultured cross sections (Fig.
7B) demonstrated a lack of circumferential orientation compared with
the circumferentially oriented cold-stored cells (Fig. 7A).
|
| |
Discussion |
|---|
|
|
|---|
Previous investigators have demonstrated an enhanced expression
and function of either the ETA or
ETB receptor subtype in different models of
arterial injury (Wang et al., 1995
; Dagassan et al., 1996
; Mathew et
al., 1996
; Hasdai et al., 1997
; Stewart, 1998
; Katwa et al., 1999
). We
hypothesized that there is an enhanced physiological function of ET
receptors in an organ culture model of the porcine right coronary
artery. Although no studies have directly addressed the possibility
that smooth muscle cells may respond differently to ET-1 if they are
isolated from the artery itself, this study uniquely demonstrates that
isolated single smooth muscle cells respond similarly as those smooth
muscle cells possessing cell-cell interactions within the vessel wall.
Our results demonstrate that both intact arterial rings and isolated smooth muscle cells display an enhanced response (i.e., tension development and Cam response, respectively) to
ET-1 with organ culture. Specifically, this study demonstrates that
organ culture enhances the physiological function of
ETA receptors in the right coronary artery.
The organ culture model has been extensively used to study cell
proliferation and migration (Gotlieb and Boden, 1984
; Newby and
Zaltsman, 1999
; Voisard et al., 1999
). We uniquely confirmed that cells
from organ-cultured arteries are undergoing cell cycling because in
intact arterial cross sections there is a greater DNA content than
cells from cold storage. This agrees with investigators who confirmed
that the relative DAPI fluorescence intensity positively correlates
with cell proliferation (McCaffrey et al., 1988
). Furthermore, the DAPI
staining in single cells from organ-cultured arterial cross sections
demonstrated a lack of orientation compared with the circumferentially
oriented cold-stored cells. The cells from organ-cultured arteries
appear to be in a migrating state. Recently, organ culture has also
been used to study receptor function and density within these
proliferating cells, such as happens in atherosclerosis (Adner et al.,
1996
, 1998a
,b
). Therefore, we used the organ culture model to determine
whether the contractile activity of coronary smooth muscle cells is
altered with arterial injury.
Our results indicate that there was no difference in the potency of
ET-1 if the artery was organ cultured. Our
pD2 values for cold-stored and
organ-cultured rings were 7.60 ± 0.13 and 7.56 ± 0.03, respectively (P > .05). This agrees with Harrison et
al. (1992)
who reported a pD2 value of
8.17 by measuring tension development in endothelium-denuded rings from
pig coronary arteries. Because the pD2
values were similar between cold-stored and organ-cultured rings, it
might be assumed that a maximal concentration of ET-1 (3 × 10
7 M) would elicit a similar contractile
response between groups as was shown by Adner et al. (1995)
using fresh
and organ-cultured human omental arteries. However, we demonstrated an
approximate 2-fold increase in isometric tension development to a
maximal concentration of ET-1 in organ-cultured arterial rings compared with cold-stored rings. In addition, using the ET-1
EC50 (as determined in the arterial rings) we
showed that ET-1 increased the Cam response 2.6-fold in single cells that were isolated from organ-cultured arteries compared with those isolated from cold-stored arteries. The
apparent higher sensitivity to ET-1 in isolated single smooth muscle
cells than in intact arterial rings appears to be due to the source of
calcium used for tension development. Our data suggest that contractile
force is highly dependent on calcium influx, and not SR calcium
release. This suggests that the greater contractile force generated in
organ-cultured rings is partially attributed to an increase in calcium
influx. Other studies have also shown that ET-1-induced calcium influx
mediates tension development (Kasuya et al., 1989
; Inui et al., 1999
).
It has been demonstrated that a sustained influx of calcium is matched
by calcium extrusion (so-called "calcium cycling"), which returns
bulk Cam to basal levels without limiting
sustained tension development (Rasmussen et al., 1989
; Bowles et al.,
1995
). Therefore, because the ET-1-induced influx of calcium is rapidly
extruded from the cell (Bowles et al., 1995
), ET-1-induced calcium
influx is not apparent using single-cell digital imaging of bulk
Cam. However, we used single-cell fura-2 digital
imaging to measure SR calcium release (Wagner-Mann and Sturek, 1991
,
1992
). Our data suggest that there is a greater enhancement of the
ET-1-mediated release of calcium from the SR with organ culture.
Investigators have found that the transient ET-1 induced intracellular
release of calcium (via inositol triphosphate) appears to be primarily
linked to mitogenesis and sensitization of the myofilaments via the
activation of protein kinase C (Assender et al., 1996
; Schiffrin and
Touyz, 1998
; Suzuki et al., 1999
). Both Douglas et al. (1994)
and
McKenna et al. (1998)
have demonstrated that ET-1 promotes neointimal
thickening in arterial injury models. Therefore, the enhanced release
of calcium from the SR with organ culture may induce cell proliferation
as is demonstrated during atherosclerotic development.
We originally hypothesized that the enhanced tension development and
Cam increase in response to ET-1 with organ
culture was due, in part, to an enhanced action of ET receptors. This
was confirmed using the nonselective ET antagonist bosentan, which inhibited both tension development in arterial rings and the
Cam response in isolated single cells. Bosentan
shifted the concentration-response relationship to the right 6-fold and
inhibited the Cam response by 80% in cells
isolated from organ-cultured arteries. Therefore, our results
corroborate those reports by investigators who have shown that ET-1
receptors are up- or down-regulated in response to a variety of
vascular pathologies and organ culture (Wang et al., 1995
; Adner et
al., 1996
, 1998a
,b
; Mathew et al., 1996
; Stewart, 1998
).
We determined the contribution of the ETA
receptor subtype in mediating the enhanced contractile and
Cam response in organ-cultured arteries using the
selective ETA antagonist BQ123. In cold-stored rings 10
6 M BQ123 was ineffective in inhibiting
the ET-1 response; only 10
5 M BQ123 inhibited
the ET-1 response. In contrast, both 10
6 and
10
5 M BQ123 were effective in shifting the
concentration-response relationship 5- and 7-fold to the right,
respectively, in organ-cultured rings. This is similar to the 6-fold
shift to the right with bosentan in organ-cultured rings. Because
10
6 M BQ123 inhibited and had no effect on
organ-cultured and cold-stored rings, respectively, this suggests that
the increased contractile response to ET-1 is principally due to
ETA receptors in organ-cultured arteries.
Isolated single cells demonstrated a similar sensitivity to BQ123 as displayed by organ-cultured arterial rings. Similar to bosentan, BQ123 decreased the Cam response approximately 80% in cells from organ culture. In cells from cold-stored arteries, BQ123 did not decrease the Cam response, whereas bosentan did decrease Cam by about 50%. In evaluating the effect of the antagonists on the Cam response we pooled both cells that did or did not respond to ET-1 in the absence and presence of the antagonist. Otherwise, in the presence of the antagonist, it would not be known whether the cells inherently did not respond to ET-1, or whether the antagonist effectively inhibited the ET-1 response. This dilution of the response to ET-1 may contribute to the apparent lack of ET-1 inhibition by BQ123 in cells from cold-stored arteries. Because only 33% of the cells from cold-stored arteries responded to ET-1 (no antagonist) this decreased the overall reported Cam response, which makes it difficult to formulate a definitive conclusion regarding the antagonism of the ET-1 Cam response in these cells. In contrast, because 75% of the cells from organ-cultured arteries responded to ET-1 (nonantagonist) there was little dilution of the Cam response to ET-1, therefore the antagonism of ET-1 is more apparent and definitive.
Unlike BQ123, the selective ETB antagonist BQ788 did not inhibit isometric tension development or the Cam response to ET-1 in both intact rings and isolated cells from organ-cultured or cold-stored arteries. In response to the selective ETB agonist sarafotoxin 6C, cells from organ-cultured arteries actually decreased their Cam response 60% compared with cells from cold storage. These Cam data suggest there may be a functional down-regulation of ETB receptors. However, it is difficult to accurately conclude there is a decreased function of ETB receptors with organ culture because our data demonstrate such a small Cam response to sarafotoxin 6C and very little contribution of ETB-mediated tension development in both normal and organ-cultured arteries.
Our results are important because ET receptors have been implicated in
atherosclerosis (Mathew et al., 1996
) and neointimal formation after
balloon angioplasty (Douglas et al., 1994
). An oral
ETA antagonist reduced neointimal hyperplasia in
a porcine model of coronary artery injury (McKenna et al., 1998
). In
addition, Katwa et al. (1999)
found that the expression of
ETA receptors is up-regulated in porcine coronary
arteries during restenosis. In contrast, Dagassan et al. (1996)
described an up-regulation of ETB receptors in atherosclerotic human
coronary arteries. However, Dagassan et al. (1996)
used the left
anterior descending coronary artery, which appears to have a greater
percentage of ETB receptors than the right
coronary artery (Harrison et al., 1992
; Godfraind, 1993
; Elmoselhi and
Grover, 1997
; Hasdai et al., 1997
). The right coronary artery, as was
used in this study, demonstrates an ETB receptor
population that mediates little vasoconstriction (Bacon and Davenport,
1996
). Therefore, the right coronary artery is a good model to use to
exclusively study the function (i.e., vasoconstriction and
Cam response) of ETA receptors.
This study uniquely demonstrates that the Cam response mediated by either the ETA or ETB receptor in isolated smooth muscle cells parallels the development of isometric tension in both cold-stored coronary arteries and organ-cultured coronary arteries. Organ culture greatly enhanced both the Cam response and isometric tension development to ET-1. Our results indicate that the increased response to ET-1 is attributed to an enhanced action of ETA receptors, and not ETB receptors.
| |
Acknowledgments |
|---|
We thank Julie Childress and Qicheng Hu for technical assistance.
| |
Footnotes |
|---|
Accepted for publication July 31, 2000.
Received for publication May 22, 2000.
1 This study was supported by National Institutes of Health Grants RR13223 and HL62522 (to M.S.) and an American Heart Association Predoctoral Fellowship (to B.J.F.H.).
Send reprint requests to: Michael Sturek, Ph.D., Department of Physiology, MA415 Medical Sciences Building, School of Medicine, University of Missouri, Columbia, MO 65212. E-mail: sturekm{at}missouri.edu
| |
Abbreviations |
|---|
ET-1, endothelin-1;
ETA, endothelinA;
ETB, endothelinB;
LAD, left anterior descending
coronary artery;
Cam, myoplasmic calcium;
DAPI, 4',6-diamidino-2-phenylindole dihydrochloride;
PSS, physiological salt
solution;
80K, 80 × 10
3 M KCl solution;
Tmax, response to a maximal
concentration of an agonist;
SR, sarcoplasmic reticulum;
OC, organ
culture;
CS, cold storage.
| |
References |
|---|
|
|
|---|
The critical importance of vascular smooth muscle cell proliferation, migration and matrix formation.
Cardiov Res
41:
345-360This article has been cited by other articles:
![]() |
S. A. Kempson, J. M. Edwards, A. Osborn, and M. Sturek Acute inhibition of the betaine transporter by ATP and adenosine in renal MDCK cells Am J Physiol Renal Physiol, July 1, 2008; 295(1): F108 - F117. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Witczak, B. R. Wamhoff, and M. Sturek Exercise training prevents Ca2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic yucatan swine J Appl Physiol, September 1, 2006; 101(3): 752 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kempson, J. M. Edwards, and M. Sturek Inhibition of the renal betaine transporter by calcium ions Am J Physiol Renal Physiol, August 1, 2006; 291(2): F305 - F313. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Maddali, D. H. Korzick, D. L. Tharp, and D. K. Bowles PKC{delta} Mediates Testosterone-induced Increases in Coronary Smooth Muscle Cav1.2 J. Biol. Chem., December 30, 2005; 280(52): 43024 - 43029. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shen, C. I. Seye, M. Wang, G. A. Weisman, P. A. Wilden, and M. Sturek Cloning, Up-Regulation, and Mitogenic Role of Porcine P2Y2 Receptor in Coronary Artery Smooth Muscle Cells Mol. Pharmacol., November 1, 2004; 66(5): 1265 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lee, B. R. Wamhoff, L. C. Katwa, H. K. Reddy, D. J. Voelker, J. L. Dixon, and M. Sturek Increased Endothelin-Induced Ca2+ Signaling, Tyrosine Phosphorylation, and Coronary Artery Disease in Diabetic Dyslipidemic Swine Are Prevented by Atorvastatin J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 132 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Wamhoff, D. K. Bowles, N. J. Dietz, Q. Hu, and M. Sturek Exercise training attenuates coronary smooth muscle phenotypic modulation and nuclear Ca2+ signaling Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2397 - H2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
|